Advanced searches left 3/3

Hormone Replacement Therapy - Europe PMC

Summarized by Plex Scholar
Last Updated: 11 May 2022

* If you want to update the article please login/register

Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause care.

Objective Inequity of access and choice of various hormone replacement therapy kits throughout the United Kingdom has been promoted. The study aims to achieve a consensus that favors greater equity in access and choice of HRT and provision of individualized care. Prosecutors with expertise in menopause care developed a revised Delphi report aimed at UK HCPs with expertise in menopause care. This group released 40 consensus statements on four major topics, relating to access and selection of different HRT products. HCP responses between June and September 2021 were measured in 150 HCP samples between June and September 2021, according to the main outcome measure. Analysis found 37/40 statements with high consensus and 3/40 statements with high agreement, with 37/40 statements achieving very high frequency, with 37/40 statements achieving high agreement, and 3/40 statements achieving high compromise. Conclusions The high rate of agreement shown shows a willingness to change the way menopause care is delivered in the United Kingdom. The suggested guidelines, which comply with the NICE recommendation for personalization of care, have the ability to increase equity in access to approved treatment options.

Source link: https://europepmc.org/article/MED/35443829

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions